The Healthcare business of Thomson Reuters continues to closely monitor the H1N1 Influenza "Swine Flu" outbreak and will communicate and respond to any changes in diagnosis or management recommendations provided by the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO).

As the industry leader in providing trusted, evidence-based information to healthcare professionals, our Micromedex® drug, disease, and patient education content reflects current treatment recommendations. We continuously monitor changes to treatment recommendations for swine influenza and will make regular updates to ensure that the information available in all Micromedex solutions is accurate, current, and comprehensive.

If you have specific questions about our content or a particular solution, please contact our Support staff at http://www.micromedex.com/support/request/ or call 1-877-843-6796, say the product name you are asking about, and select option 4.